Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Pathology

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ajpath.2011.07.004PMID 21854751PMCID PMC3181340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer's disease.

  2011cited by this paper
• Structural abnormalities in the cortex of the rTg4510 mouse model of tauopathy: a light and electron microscopy study

  2011cited by this paper
• Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.

  2011cited by this paper
• The many faces of tau.

  2011cited by this paper
• Cortico-Cortical Connectivity between Right Parietal and Bilateral Primary Motor Cortices during Imagined and Observed Actions: A Combined TMS/tDCS Study

  2011cited by this paper
• Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice

  2011cited by this paper
• Preparation and characterization of neurotoxic tau oligomers.

  2010cited by this paper
• Single-synapse analysis of a diverse synapse population: proteomic imaging methods and markers.

  2010cited by this paper
• Mitochondrial fusion and fission in cell life and death

  2010influential reference
• Caspase activation precedes and leads to tangles

  2010cited by this paper
• Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model

  2010cited by this paper
• Alzheimer's disease.

  2010cited by this paper
• Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines

  2010cited by this paper
• Amyloid-β Peptide Oligomers Disrupt Axonal Transport through an NMDA Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase Kinase 3β in Primary Cultured Hippocampal Neurons

  2010cited by this paper
• The Alzheimer's Disease Mitochondrial Cascade Hypothesis

  2010influential reference
• Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology.

  2010influential reference
• Aggregation of Detergent-insoluble Tau Is Involved in Neuronal Loss but Not in Synaptic Loss*

  2010cited by this paper
• Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo

  2010cited by this paper
• Correlative Microscopy of Densely Labeled Projection Neurons Using Neural Tracers

  2010cited by this paper
• Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs.

  2010cited by this paper
• High resolution three-dimensional reconstruction of the collagenous matrix of the human optic nerve head.

  2010cited by this paper
• A NH2 Tau Fragment Targets Neuronal Mitochondria at AD Synapses: Possible Implications for Neurodegeneration

  2010cited by this paper
• Alzheimer's Proteins, Oxidative Stress, and Mitochondrial Dysfunction Interplay in a Neuronal Model of Alzheimer's Disease

  2010cited by this paper
• Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.

  2010cited by this paper
• The role of tau in neurodegeneration

  2009cited by this paper
• Axonal Transport Defects in Neurodegenerative Diseases

  2009cited by this paper
• Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases

  2009cited by this paper
• ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain

  2009cited by this paper
• The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease

  2009cited by this paper
• The mechanism of Ca2+ -dependent regulation of kinesin-mediated mitochondrial motility.

  2009cited by this paper
• Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease

  2009cited by this paper
• The amino terminus of tau inhibits kinesin‐dependent axonal transport: Implications for filament toxicity

  2009cited by this paper
• Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

  2009cited by this paper
• Caspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons

  2009cited by this paper
• Tau pathophysiology in neurodegeneration: a tangled issue.

  2009cited by this paper
• Divergent Pathways Mediate Spine Alterations and Cell Death Induced by Amyloid-β, Wild-Type Tau, and R406W Tau

  2009cited by this paper
• Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer's disease?

  2009cited by this paper
• Faculty Opinions recommendation of Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau.

  2009cited by this paper
• Differential Regulation of Dynein and Kinesin Motor Proteins by Tau

  2008cited by this paper
• Tau Aggregates: Toxic, Inert, or Protective Species?

  2008cited by this paper
• Tau inhibits anterograde axonal transport and perturbs stability in growing axonal neurites in part by displacing kinesin cargo: neurofilaments attenuate tau-mediated neurite instability.

  2008cited by this paper
• Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy

  2007cited by this paper
• Missorting of Tau in Neurons Causes Degeneration of Synapses That Can Be Rescued by the Kinase MARK2/Par-1

  2007cited by this paper
• Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits.

  2007cited by this paper
• Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

  2007cited by this paper
• Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy.

  2006influential reference
• Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

  2006influential reference
• Neurotoxic Calcium Transfer from Endoplasmic Reticulum to Mitochondria Is Regulated by Cyclin-Dependent Kinase 5-Dependent Phosphorylation of Tau

  2005cited by this paper
• Neuronal microtubules: when the MAP is the roadblock.

  2005cited by this paper
• Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice*

  2005cited by this paper
• The axonal transport of mitochondria

  2005cited by this paper
• Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions.

  2005cited by this paper
• The axonal transport of mitochondria

  2005cited by this paper
• Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

  2005influential reference
• Infectious disease: Unravelling SARS lethality

  2005cited by this paper
• The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses.

  2004cited by this paper
• Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

  2003cited by this paper
• Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

  2002cited by this paper
• Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles

  2001cited by this paper
• A pyramid approach to subpixel registration based on intensity

  1998cited by this paper
• Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease

  1998cited by this paper
• Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Edinburgh Research Explorer Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport

  year unknowninfluential reference

• Diverse influences on tau aggregation and implications for disease progression

  2025cites this paper
• Neuronal Distribution of Tau Pathology, Microglial Gene Expression Trajectories, and Resilience to Alzheimer disease

  2025cites this paper
• Role of Mitochondrial Calcium Dysregulation in Alzheimer’s Disease Pathogenesis

  2025cites this paper
• Tau–Mitochondria Interactions in Neurodegeneration: Mechanisms and Therapeutic Potential

  2025cites this paper
• Spinal cord Tau pathology induces tactile deficits and cognitive impairment in Alzheimer’s disease via dysregulation of CCK neurons

  2025cites this paper
• Tau Protein Disrupts Mitochondrial Homeostasis in a Yeast Model: Implications for Alzheimer’s Disease

  2025cites this paper
• Extracellular PHF-tau modulates astrocyte mitochondrial dynamics and mediates neuronal connectivity

  2025cites this paper
• From Obesity to Mitochondrial Dysfunction in Peripheral Tissues and in the Central Nervous System

  2025cites this paper
• Implications of mitochondrial phosphatidylethanolamine in neuronal health and neurodegeneration.

  2025cites this paper
• Reversal of neuronal tau pathology via adiponectin receptor activation

  2025cites this paper
• Mechanisms of Alcohol Interference with Hippocampal Neurogenesis and its Repair Strategies

  2025cites this paper
• Neurons ensheathed by perineuronal nets are prone to hyperphosphorylation of tau protein in the hibernating Syrian hamster brain

  2025cites this paper
• Profiling the impact of different tau species on glial cell biology

  2025cites this paper
• Leveraging Proteomics to Explore the Molecular Mechanisms of Primary Tauopathies

  2025cites this paper
• Mitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies

  2025cites this paper
• Hippocampal mitophagy alterations in MAPT-associated frontotemporal dementia with parkinsonism

  2025cites this paper
• LRRK2-mediated mitochondrial dysfunction in Parkinson’s disease

  2025cites this paper
• Excessive Alcohol Use as a Risk Factor for Alzheimer's Disease: Epidemiological and Preclinical Evidence.

  2025cites this paper
• Mitochondrial bioenergetics stimulates autophagy for pathological MAPT/Tau clearance in tauopathy neurons

  2024cites this paper
• Mitochondrial dysfunction and Alzheimer’s disease: pathogenesis of mitochondrial transfer

  2024cites this paper
• Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change

  2024cites this paper
• Total Tau Protein Mediates the Association of Ischemic Cerebrovascular Disease with Cognitive Decline

  2024cites this paper
• Calcium Balance through Mutual Orchestrated Inter-organelle Communication: A Pleiotropic Target for Combating Alzheimer's Disease.

  2024cites this paper
• Mitochondrial plasticity and synaptic plasticity crosstalk; in health and Alzheimer's disease

  2024cites this paper
• Tau Oligomers as Pathogenic Seeds: Preparation, Characterization, and Propagation In Vitro and In Vivo.

  2024cites this paper
• Research Progress of Mitophagy in Alzheimer's Disease.

  2024cites this paper
• Mechanistic insights and emerging therapeutic stratagems for Alzheimer's disease.

  2024cites this paper
• Lung endothelium, tau, and amyloids in health and disease

  2023cites this paper
• Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?

  2023cites this paper
• Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice

  2023cites this paper
• Focusing on oligomeric tau as a therapeutic target in Alzheimer’s disease and other tauopathies

  2023cites this paper
• The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges.

  2023cites this paper
• Convergent mechanisms of microglia‐mediated synaptic dysfunction contribute to diverse neuropathological conditions

  2023cites this paper
• Recent advances in nanotechnology for combating Alzheimer's disease

  2023cites this paper
• Pathological Impact of Tau Proteolytical Process on Neuronal and Mitochondrial Function: a Crucial Role in Alzheimer’s Disease

  2023cites this paper
• Latest assessment methods for mitochondrial homeostasis in cognitive diseases

  2023cites this paper
• Nano‐Brake Halts Mitochondrial Dysfunction Cascade to Alleviate Neuropathology and Rescue Alzheimer's Cognitive Deficits

  2023cites this paper
• Site‐specific phosphorylation of tau impacts mitochondrial function and response to stressors

  2023cites this paper
• Site-specific phosphorylation of tau impacts mitochondrial biology and response to stressors

  2023cites this paper
• Effects of Redox Homeostasis and Mitochondrial Damage on Alzheimer’s Disease

  2023cites this paper
• Multi-omics analysis revealed the role of CCT2 in the induction of autophagy in Alzheimer’s disease

  2023cites this paper
• Potential Active Marine Peptides as Anti-Aging Drugs or Drug Candidates

  2023cites this paper
• Insights from Drosophila on Aβ- and tau-induced mitochondrial dysfunction: mechanisms and tools

  2023cites this paper
• Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression

  2023cites this paper
• Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review

  2023cites this paper
• Decoding the role of transcriptomic clocks in the human prefrontal cortex

  2023cites this paper
• Post-mortem AT-8 reactive tau species correlate with non-plaque Aβ levels in the frontal cortex of non-AD and AD brains

  2023cites this paper
• Ubiquitin phosphorylation accelerates protein aggregation and promotes neurodegeneration in the aging brain

  2023cites this paper
• Frontotemporal Dementia P301L Mutation Potentiates but Is Not Sufficient to Cause the Formation of Cytotoxic Fibrils of Tau

  2023cites this paper
• Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies

  2023cites this paper
• Genetically Engineered Triple MAPT-Mutant Human-Induced Pluripotent Stem Cells (N279K, P301L, and E10+16 Mutations) Exhibit Impairments in Mitochondrial Bioenergetics and Dynamics

  2023cites this paper
• Mitochondrial complex I as a diagnostic and therapeutic target in a mouse model of tauopathy

  2023cites this paper
• The role of N-methyl-D-aspartate glutamate receptors in Alzheimer's disease: from pathophysiology to therapeutic approaches.

  2023cites this paper
• Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease

  2023cites this paper
• Development of a system to analyze oral frailty associated with Alzheimer's disease using a mouse model

  2022cites this paper
• Hyperphosphorylated Human Tau Accumulates at the Synapse, Localizing on Synaptic Mitochondrial Outer Membranes and Disrupting Respiration in a Mouse Model of Tauopathy

  2022cites this paper
• Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer’s disease

  2022influential citation
• Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy

  2022cites this paper
• Effect of Tau Protein on Mitochondrial Functions

  2022cites this paper
• Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes

  2022cites this paper
• Oxidative Stress in Tauopathies: From Cause to Therapy

  2022cites this paper
• Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice

  2022cites this paper
• Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy.

  2022cites this paper
• Coenzyme A-Dependent Tricarboxylic Acid Cycle Enzymes Are Decreased in Alzheimer’s Disease Consistent With Cerebral Pantothenate Deficiency

  2022cites this paper
• Synapse pathology in Alzheimer's disease.

  2022cites this paper
• Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope

  2022cites this paper
• Synaptic degeneration in Alzheimer disease

  2022cites this paper
• Programming axonal mitochondrial maintenance and bioenergetics in neurodegeneration and regeneration.

  2022cites this paper
• Decreased anterograde transport coupled with sustained retrograde transport contributes to reduced axonal mitochondrial density in tauopathy neurons

  2022cites this paper
• Dysregulated Ca2+ Homeostasis as a Central Theme in Neurodegeneration: Lessons from Alzheimer’s Disease and Wolfram Syndrome

  2022cites this paper
• Mechanistic Insights into Selective Autophagy Subtypes in Alzheimer’s Disease

  2022cites this paper
• Key brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease

  2022cites this paper
• Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies

  2022cites this paper
• Therapeutic effects of carvacrol on beta‐amyloid‐induced impairments in in vitro and in vivo models of Alzheimer's disease

  2021cites this paper
• Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia

  2021cites this paper
• Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease

  2021cites this paper
• The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

  2021cites this paper
• Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis

  2021cites this paper
• Effects of Magnesium Orotate, Benfotiamine and a Combination of Vitamins on Mitochondrial and Cholinergic Function in the TgF344-AD Rat Model of Alzheimer’s Disease

  2021cites this paper
• Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development

  2021cites this paper
• Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models.

  2021cites this paper
• Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor

  2021cites this paper
• Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer’s Disease

  2021cites this paper
• Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline

  2021cites this paper
• Effects of food-derived bioactive peptides on cognitive deficits and memory decline in neurodegenerative diseases: A review

  2021cites this paper
• Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s Disease

  2021cites this paper
• Impact of Tau on Neurovascular Pathology in Alzheimer's Disease

  2021cites this paper
• Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer’s Disease

  2021cites this paper
• The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer’s Disease Type

  2021cites this paper
• GSK3 as a Regulator of Cytoskeleton Architecture: Consequences for Health and Disease

  2021cites this paper
• Mitochondrial links between brain aging and Alzheimer’s disease

  2021cites this paper
• Defective Autophagy and Mitophagy in Alzheimer’s Disease: Mechanisms and Translational Implications

  2021cites this paper
• Reassessment of Pioglitazone for Alzheimer’s Disease

  2021cites this paper
• Metabolic Regulation of Glia and Their Neuroinflammatory Role in Alzheimer's Disease

  2021cites this paper
• Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease

  2021cites this paper
• Tau Oligomers Neurotoxicity

  2021cites this paper
• Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain

  2021cites this paper
• Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis

  2021cites this paper
• A mitochondria cluster at the proximal axon initial segment controls axodendritic TAU trafficking in rodent primary and human iPSC-derived neurons

  2021cites this paper
• Tau Pathology Triggered by Spinal Cord Injury Can Play a Critical Role in the Neurotrauma Development

  2020cites this paper